- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01799707
Vision Restoration Training in Glaucoma (gVRT)
Vision Restoration Training in Glaucoma - A Double-blind, Randomized, Placebo-controlled Clinical Trial
Importance: Visual field loss after retinal damage in glaucoma is considered irreversible and methods are needed to achieve vision restoration. Behavioral vision restoration training (VRT), shown to improve visual fields in hemianopia and optic nerve damage, might comprise such a method.
Objective: To determine if behaviorally activating areas of residual visual (ARV) using VRT by daily one hour training for 3 months improves detection performance in perimetry compared to a vision discrimination task in the intact visual field sector.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Design: Prospective, randomized, double-blind, placebo controlled trial. Setting: Ambulatory care and home training Participants: Volunteer sample of glaucoma patients (25-80 yrs old) with stable visual fields and well controlled intraocular pressure (IOP).
Intervention: Computer-based home training with VRT (n=15) or placebo discrimination training (n=15).
Main Outcome Measures: The primary endpoint is change in detection performance in High Resolution Perimetry (HRP). Secondary endpoints are 30° white/white and 30° blue/yellow near-threshold perimetry. Further measures are eye movements, vision-related quality of life (vQoL) as assessed with (NEI-VFQ) and health-related quality of life (hQoL) using SF-36 Health Survey-Short Form.
Investigators hypothesize that VRT will improve visual performance in glaucoma
Study Type
Enrollment (Actual)
Phase
- Phase 2
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Visual filed defect caused by glaucoma
- Presence of a reproducible and stable visual field defect inside 30° eccentricity in at least one eye in 2 consecutive ophthalmologic visits during the last 12 months before recruitment
- Well controlled intraocular pressure (IOP), and (iv) age between 25 and 80 years
Exclusion Criteria:
- History of any medical condition precluding scheduled study visits or completion of the study (e.g. unstable cardiovascular disease)
- History of any chronic degenerative or chronic inflammatory disease that could affect the visual field (e.g. multiple sclerosis, tumor
- History of trauma or any non-glaucoma ocular diseases (e.g. diabetic retinopathy, age-related macular degeneration, macular detachment, vascular occlusion
- Severe cognitive or motor impairments
- Insufficient fixation ability
- Photosensitivity
- Intraocular surgery or laser treatment performed within the previous 12 months before recruitment; OR
- Scheduled intraocular surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: vision restoration training
Vision restoration training (VRT): visual stimuli repetitively presented to stimulate areas of residual vision.
The training consists of luminance increment stimuli similar to perimetry and the task isa simple detection task (pressing a key whenever a target stimulus was detected).
|
visual stimuli repetitively presented to stimulate areas of residual vision.
The training consists of luminance increment stimuli similar to perimetry and the task isa simple detection task (pressing a key whenever a target stimulus was detected).
Other Names:
|
|
Placebo Comparator: Discrimination training
Discrimination training.
Here, the stimulus is a line segment (bar) which is always presented within the central ±5° visual field in one of four possible random orientations: horizontal, vertical, oblique to the right or oblique to the left.
If the patient has visual field defects in this central area, 80% of the stimuli are presented in the intact part of the training region.
The task is to identify the orientation of the line segment and press, as fast as possible, one of 4 assigned buttons on the keyboard.
|
the stimulus is a line segment (bar) which is always presented within the central ±5° visual field in one of four possible random orientations: horizontal, vertical, oblique to the right or oblique to the left.
If the patient has visual field defects in this central area, 80% of the stimuli are presented in the intact part of the training region.
The task is to identify the orientation of the line segment and press, as fast as possible, one of 4 assigned buttons on the keyboard.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detection accuracy change in percent over baseline of the visual field
Time Frame: between baseline and 3 months of training
|
visual stimulus detection in residual and absolutely defect field of vision will be assessed using computer-based high resolution perimetry (HRP)
|
between baseline and 3 months of training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in visual stimulus perimetric detection rate
Time Frame: between baseline and 3 months of training
|
improvement of visual field in near-threshold perimetry measured by static perimetry (average threshold in db, average excentricity in degrees of visual angle
|
between baseline and 3 months of training
|
|
improvement of reaction time
Time Frame: between baseline and 3 months of training
|
change in average reaction time in ms, measured by HRP
|
between baseline and 3 months of training
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Eye movement control
Time Frame: between baseline and 3 months of training
|
visual stimulus detection in residual and absolutely defect field of vision will be assessed using computer-based high resolution perimetry (HRP)
|
between baseline and 3 months of training
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Bernhard A Sabel, PhD, University of Magdeburg
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VRT 03-2003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glaucoma
-
Hospices Civils de LyonRecruitingOpen-angle Glaucoma | Glaucoma Eye | Pigmentary Glaucoma | Closed-Angle Glaucoma | Pseudo Exfoliative SyndromeFrance
-
Imperial College Healthcare NHS TrustIRIDEX CorporationNot yet recruitingGlaucoma | Glaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma Secondary | Glaucoma Traumatic | Glaucoma Uveitic
-
Wills EyeIOP OphthalmicsTerminatedPrimary Open Angle Glaucoma | Neovascular Glaucoma | Uveitic Glaucoma | Pseudoexfoliation Glaucoma | Primary Angle Closure Glaucoma | Pigmentary Glaucoma | Traumatic GlaucomaUnited States
-
University of MiamiAbbVieRecruitingOcular Hypertension | Glaucoma | Open-Angle Glaucoma | Glaucoma SuspectUnited States
-
Ngoc Nguyen Inc.Alcon ResearchNot yet recruitingGlaucoma | Glaucoma, Open Angle | Open Angle Glaucoma (OAG) | Normal Tension Glaucoma (NTG)United States
-
Isfahan University of Medical SciencesActive, not recruitingAngle Closure Glaucoma | Glaucoma EyeIran
-
Centre hospitalier de l'Université de Montréal...CompletedGlaucoma | Glaucoma, Open-Angle | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma and Ocular Hypertension | Glaucoma, Uncompensated | Glaucoma SecondaryCanada
-
Henry Ford Health SystemNot yet recruitingPrimary Open Angle Glaucoma (POAG) | Secondary Open Angle Glaucoma | Open Angle Glaucoma (OAG)United States
-
Pro Top & Mediking Company LimitedCompletedOpen Angle Glaucoma | Neovascular Glaucoma | Angle Closure Glaucoma | Uveitis Glaucoma | Young Age Glaucoma | High Risk PatientEstonia
-
Sanoculis LtdCompletedPrimary Open Angle Glaucoma | Pigmentary Glaucoma | Pseudoexfoliative GlaucomaIsrael
Clinical Trials on vision restoration training
-
University of MagdeburgCompletedBrain Injuries, Traumatic | HemianopiaGermany
-
VA Office of Research and DevelopmentTerminated
-
Emory UniversityCompletedNon-Arteritic Anterior Ischemic Optic NeuropathyUnited States
-
Beth Israel Deaconess Medical CenterCompletedScotoma | Hemianopia | Quadrantanopia | Visual Field Loss
-
University of California, BerkeleyNational Eye Institute (NEI)Completed
-
Marmara UniversityCompletedHealth Individuals | AtlhetesTurkey
-
Marmara UniversityCompletedHealth IndividualsTurkey
-
University of South-Eastern NorwayLovisenberg Diakonale HospitalRecruitingStroke | Hemianopia | Visual Field LossNorway
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingAxial Elongation | Adolescents and Children | Naked Eye 3D Vision Training | Visual Function
-
University of RochesterEnrolling by invitationStroke, Ischemic | Stroke Hemorrhagic | Hemianopia, Homonymous | Visual Field Defect, Peripheral | Hemianopsia | Quadrantanopia | Occipital Lobe Infarct | Vision Loss PartialUnited States